Ameriprise’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-42,003
| Closed | -$2.86M | – | 4110 |
|
|
2022
Q3 | $2.86M | Buy |
+42,003
| New | +$2.86M | ﹤0.01% | 2602 |
|
|
2022
Q2 | – | Sell |
-13,559
| Closed | -$470K | – | 4029 |
|
|
2022
Q1 | $470K | Sell |
13,559
-21,846
| -62% | -$757K | ﹤0.01% | 3509 |
|
|
2021
Q4 | $1.04M | Buy |
+35,405
| New | +$1.04M | ﹤0.01% | 3234 |
|
|
2021
Q3 | – | Sell |
-15,028
| Closed | -$526K | – | 3989 |
|
|
2021
Q2 | $526K | Sell |
15,028
-17,382
| -54% | -$608K | ﹤0.01% | 3439 |
|
|
2021
Q1 | $1.32M | Sell |
32,410
-2,399
| -7% | -$97.9K | ﹤0.01% | 3021 |
|
|
2020
Q4 | $1.51M | Buy |
34,809
+10,441
| +43% | +$452K | ﹤0.01% | 2908 |
|
|
2020
Q3 | $1.34M | Sell |
24,368
-40,115
| -62% | -$2.21M | ﹤0.01% | 2852 |
|
|
2020
Q2 | $4.07M | Buy |
64,483
+40,058
| +164% | +$2.53M | ﹤0.01% | 2207 |
|
|
2020
Q1 | $1.25M | Sell |
24,425
-6,052
| -20% | -$309K | ﹤0.01% | 2723 |
|
|
2019
Q4 | $2.42M | Buy |
30,477
+7,456
| +32% | +$593K | ﹤0.01% | 2633 |
|
|
2019
Q3 | $1.12M | Buy |
23,021
+2,440
| +12% | +$118K | ﹤0.01% | 2978 |
|
|
2019
Q2 | $1.08M | Sell |
20,581
-119
| -0.6% | -$6.26K | ﹤0.01% | 3026 |
|
|
2019
Q1 | $1.1M | Buy |
20,700
+9,214
| +80% | +$487K | ﹤0.01% | 2992 |
|
|
2018
Q4 | $470K | Buy |
+11,486
| New | +$470K | ﹤0.01% | 3200 |
|
|
2018
Q3 | – | Sell |
-49,303
| Closed | -$2.23M | – | 3789 |
|
|
2018
Q2 | $2.23M | Sell |
49,303
-25,699
| -34% | -$1.16M | ﹤0.01% | 2690 |
|
|
2018
Q1 | $3.62M | Buy |
75,002
+43,503
| +138% | +$2.1M | ﹤0.01% | 2397 |
|
|
2017
Q4 | $1.24M | Sell |
31,499
-9,627
| -23% | -$379K | ﹤0.01% | 2877 |
|
|
2017
Q3 | $1.28M | Buy |
41,126
+402
| +1% | +$12.5K | ﹤0.01% | 2853 |
|
|
2017
Q2 | $1.11M | Sell |
40,724
-248
| -0.6% | -$6.78K | ﹤0.01% | 2895 |
|
|
2017
Q1 | $1.51M | Buy |
+40,972
| New | +$1.51M | ﹤0.01% | 2703 |
|